Cargando…
DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review
SIMPLE SUMMARY: Colorectal cancer (CRC) patients with peritoneal metastases (PM) have a poor prognosis. Currently, research has been ongoing to develop new treatment options for CRC patients with PM. DNA/RNA alterations identification in the primary tumor might help identify patients who are at high...
Autores principales: | Heuvelings, Danique J. I., Wintjens, Anne G. W. E., Luyten, Julien, Wilmink, Guus E. W. A., Moonen, Laura, Speel, Ernst-Jan M., de Hingh, Ignace H. J. T., Bouvy, Nicole D., Peeters, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856984/ https://www.ncbi.nlm.nih.gov/pubmed/36672497 http://dx.doi.org/10.3390/cancers15020549 |
Ejemplares similares
-
Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer
por: Heuvelings, Danique J. I., et al.
Publicado: (2023) -
Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021) -
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review
por: Wintjens, Anne G. W. E., et al.
Publicado: (2022) -
Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model
por: Wintjens, Anne G. W. E., et al.
Publicado: (2023) -
Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)